Deep learning for cardiovascular medicine: a practical primer

Abstract

Deep learning (DL) is a branch of machine learning (ML) showing increasing promise in medicine, to assist in data classification, novel disease phenotyping and complex decision making. Deep learning is a form of ML typically implemented via multi-layered neural networks. Deep learning has accelerated by recent advances in computer hardware and algorithms and is increasingly applied in e-commerce, finance, and voice and image recognition to learn and classify complex datasets. The current medical literature shows both strengths and limitations of DL. Strengths of DL include its ability to automate medical image interpretation, enhance clinical decision-making, identify novel phenotypes, and select better treatment pathways in complex diseases. Deep learning may be well-suited to cardiovascular medicine in which haemodynamic and electrophysiological indices are increasingly captured on a continuous basis by wearable devices as well as image segmentation in cardiac imaging. However, DL also has significant weaknesses including difficulties in interpreting its models (the ‘black-box’ criticism), its need for extensive adjudicated (‘labelled’) data in training, lack of standardization in design, lack of data-efficiency in training, limited applicability to clinical trials, and other factors. Thus, the optimal clinical application of DL requires careful formulation of solvable problems, selection of most appropriate DL algorithms and data, and balanced interpretation of results. This review synthesizes the current state of DL for cardiovascular clinicians and investigators, and provides technical context to appreciate the promise, pitfalls, near-term challenges, and opportunities for this exciting new area.

Network Medicine: A Clinical Approach for Precision Medicine and Personalized Therapy in Coronary Heart Disease

“…Experimental studies have investigated a net-Recently, in medical imaging, we have assisted with a shift from qualitative imaging to quantitative assessment through the extraction of imaging biomarkers by applying artificial intelligence 81) . Machine and deep learning approaches involve using raw imaging data to extrapolate imaging features and, together with clinical information and big data, are processed into algorithms to build disease models and neural networks in order to improve diagnosis, make clinical decisions, and predict outcomes towards a personalized medical approach 81) . Recent studies on machine learning approaches exploiting CTCA showed high prognostic accuracy in risk stratification and prediction of mortality in CHD patients [82][83][84] .…”

Wireless monitoring and artificial intelligence: A bright future in cardiothoracic surgery

“…All these algorithms have been mostly used in the fields of imaging, clinical-risk stratification, and precision medicine. 16 Two of the supervised learning techniques are neural networks and deep learning. Neural networks that process solutions as a brain would do, have been used successfully to classify cardiac abnormalities.…”

Big Data in sleep apnoea: Opportunities and challenges

“…There is a need for machine learning and deep learning algorithms associated with high computational capacities. For clinicians, understanding machine learning ‘black boxes’ and to be confident in clinical decisions and therapeutic allocations proposed by AI is fascinating but troublesome . Performance in the development of such algorithms demands a strong collaboration between clinicians and data scientists from the precise formulation of problems to a common and balanced interpretation of results .…”